Optibiotix Health (OPTI)

 

OPTI Share PerformanceMore

52 week high90.00 03/04/17
52 week low52.00 16/08/17
52 week change -13.20 (-18.33%)
4 week volume7,398,643 25/01/18
price58.80
price date1519131611
close58.50

Media for (OPTI)

Latest NewsMore

Exercise of warrant and issue of equity

RNS Number: 9732D OptiBiotix Health PLC 06 February 2018 OptiBiotix Health plc ("OptiBiotix" or the "Company") Exercise of warrant and issue of equity OptiB i ot i x H ealth p l c (A I M: O P TI), a li f e sc i ences bu s i n ess d e ve l o p i n g c o m p o u n d s to tack l e o b esi t y, h i g h chole s te r ol, d ia b ete s has received a notification for the exercise of warran...

Director Deals - Optibiotix Health Plc (OPTI)

Neil Davidson, Chairman, bought 165,000 shares in the company on the 1st February 2018 at a price of 60.00p. The Director...

Director's dealing

RNS Number: 6755D OptiBiotix Health PLC 01 February 2018 OptiBiotix Health plc ("OptiBiotix" or the "Company") Director's dealing OptiB i ot i x H ealth p l c (A I M: O P TI), a li f e sc i ences bu s i n ess d e ve l o p i n g c o m p o u n d s to tack l e o b esi t y, h i g h chole s te r ol, d ia b ete s was notified today that Neil Davidson, Non-Executive Chairman of the Co...

Exercise of warrant and issue of equity

RNS Number: 3745D OptiBiotix Health PLC 30 January 2018 OptiBiotix Health plc ("OptiBiotix" or the "Company") Exercise of warrant and issue of equity OptiB i ot i x H ealth p l c (A I M: O P TI), a li f e sc i ences bu s i n ess d e ve l o p i n g c o m p o u n d s to tack l e o b esi t y, h i g h chole s te r ol, d ia b ete s has received a notification for the exercise of warrant...

Result of Meeting

RNS Number: 9408C OptiBiotix Health PLC 25 January 2018 25 January 2018 O p t i B i o t i x H eal th p l c ( "O p t i Bi o t i x" o r t h e "C o m pan y" ) Result of GM OptiB i o t i x H ealth p l c (A I M: O P T I ), a li f e sc i ences bu s i n ess d e v e l o p i n g c o m p o u n d s to tac k l e o b esi t y , h i g h chole s t e r o l a n d d ia b e t e s , announces that at the General ...

OptiBiotix reports successful taste study results

OptiBiotix Health said results form human a taste study testing its anti-obesity products were successful. "The results of thi...

SweetBiotix? development: human taste studies

RNS Number: 5937C OptiBiotix Health PLC 23 January 2018 O p t i B i o t i x H eal th p l c ( "O p t i Bi o t i x" o r t h e "C o m pan y" ) SweetBiotix development: Results of further human taste studies OptiB i o t i x H ealth p l c (A I M: O P T I ), a li f e sc i ences bu s i n ess d e v e l o p i n g c o m p o u n d s to tac k l e o b esi t y , h i g h chole s t e r o l a n d d ia b e t e...

OptiBiotix Health to present in Barcelona

OptiBiotix Health said it had an abstract accepted for presentation at ProBiota 2018 in Barcelona from February 7 to 9. Pro...

Fundamental DataMore

EPS-1.67
Dividend yield0 %

Latest discussion posts More

  • Re: News flow...?

    Agree, 'share price could do with a boost' but OPTI has been singularly slow in converting these 'big' deals into profit. And I don't see a change in the downward trend until ...
    15-Feb-2018
    alpal
  • News flow...?

    Its actually been two months since the last deal was announced. With a potential 30 deals in the pipeline I would of thought there would have been another by now. Share price ...
    14-Feb-2018
    whenimrich com
  • Re: Director Buying

    now showing 10:52:00 01-Feb-2018 60.00 GBX 165,000 99,000.00 Off-book AIMX AMND LRGS mol
    1-Feb-2018
    mol42

Users' HoldingsMore

Users who hold Optibiotix Health also hold..

Codes & Symbols

ISINGB00BP0RTP38
SymbolsOPTI, LSE:OPTI, OPTI.L, OPTI:LN, LON:OPTI, XLON:OPTI

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account